Tuesday, December 1, 2009

Hemispherx Biopharma Receives Complete Response Letter From FDA on Ampligen(R) New Drug Application for Chronic.. http://bit.ly/8ZDVJG
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)